Clinical value of CTLA4 combined with clinicopathological factors in evaluating the prognosis of breast cancer | Zendy

Junyi Wu | Zendy; Lei Li | Zendy; Jiayi Chen | Zendy; Yuan Liu | Zendy; Junming Xu | Zendy; Zhihai Peng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical value of CTLA4 combined with clinicopathological factors in evaluating the prognosis of breast cancer

Author(s) -

Junyi Wu,

Lei Li,

Jiayi Chen,

Yuan Liu,

Junming Xu,

Zhihai Peng

Publication year - 2020

Publication title -

gland surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.643

H-Index - 22

eISSN - 2227-8575

pISSN - 2227-684X

DOI - 10.21037/gs-20-359

Subject(s) - medicine , breast cancer , value (mathematics) , oncology , cancer , bioinformatics , gynecology , statistics , mathematics , biology

Clinical prediction of breast cancer prognosis relies on both clinical-pathological features and biological markers. Many studies have revealed that tumor cytotoxic T lymphocyte antigen 4 (CTLA4) expression may present prognostic predicting value in cancers. We intended to explore the prognostic value of significant clinicopathological parameters and CTLA4 for predicting survival of patients with breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research